US stocks had started last week on a positive note, with the Nasdaq notching a record close on Monday, as markets enthusiastically awaited quarterly results from major companies. Investors rejoiced positive news related to coronavirus vaccine candidates. AstraZeneca and the University of Oxford announced promising results from their covid-19 vaccine candidate in Phase 1 clinical
US stocks started the week on a strong note on Monday last week, as investors cheered news of positive trial results for covid-19 vaccine candidates. Pfizer reported that two of its vaccine candidates had been awarded FDA’s Fast Track designation. Moderna joined in to issue some encouraging data for its covid-19 candidate, showing that the
US stocks started the week on a positive note after China’s blue-chip stocks surged to multi-year highs. As coronavirus cases continued to rise in various states in the US and other parts of the world, tech stocks climbed, taking the Nasdaq to a new high. The US services index also returned to expansion territory, with
US markets started the week on a positive note despite a spike in new coronavirus cases. Various states in the US, including Texas and Florida, have reversed their reopening measures after witnessing a record rise in cases last week, including the highest single-day infections of 52,000 on Wednesday. Investors cheered news of Pfizer and German
US markets ended at their lowest level in around two weeks on Friday, with concerns around the record rise in new infections. Wall Street was looking to extend the previous week’s rally, but failed to build on gains as various states in the US continued reporting a rise in daily cases, forcing Texas and Florida
US stocks clawed back some of its losses last week, after nosediving the week before. Markets were supported by the Federal Reserve’s announcement on Monday around its plans to begin buying individual corporate bonds in addition to the ETFs already being purchased. The latest move by the Fed comes a week after the FOMC (Federal
After surging for several weeks on hopes of a fast rebound in the economy, US stocks struggled to carry the momentum forward last week. The major US indices recorded sharp losses for the week, despite the Nasdaq breaching the 10,000 mark for the first time in its history, during the week. Gloom gripped the market
The last trading day of the week brought a big surprise to the markets, as the May jobs report showed an unexpected increase in payroll numbers and a decline in the unemployment rate. The Bureau of Labor Statistics Friday reported a decline in the US unemployment rate to 13.3% in May, from 14.7% in the
The holiday-shortened week started on a positive note with another pharma company announcing development plans for its novel coronavirus vaccine candidate. Novavax disclosed on Monday that it had started the Phase 1 clinical study for its covid-19 candidate, NVX-CoV2373, and is expecting to release the preliminary results in July. US stocks rallied last week, as
Last week started on a positive note with Moderna being among the latest companies to announce encouraging interim Phase 1 data for a covid-19 vaccine candidate. The company, which is partnering with the National Institutes of Health, said that its candidate, mRNA-1273, is likely to enter Phase 3 trials in June subject to earlier trial
